acetazolamide

Generic: acetazolamide

Labeler: chartwell rx, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name acetazolamide
Generic Name acetazolamide
Labeler chartwell rx, llc
Dosage Form TABLET
Routes
ORAL
Active Ingredients

acetazolamide 125 mg/1

Manufacturer
Chartwell RX, LLC

Identifiers & Regulatory

Product NDC 62135-607
Product ID 62135-607_2420d256-1179-5cf2-e063-6394a90ae9a2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA205530
Listing Expiration 2026-12-31
Marketing Start 2016-10-27

Pharmacologic Class

Established (EPC)
carbonic anhydrase inhibitor [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa]
Chemical Structure
sulfonamides [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 62135607
Hyphenated Format 62135-607

Supplemental Identifiers

RxCUI
197303 197304
UPC
0362135607128 0362135608125
UNII
O3FX965V0I
NUI
N0000175517 N0000000235 M0020790

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name acetazolamide (source: ndc)
Generic Name acetazolamide (source: ndc)
Application Number ANDA205530 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 125 mg/1
source: ndc
Packaging
  • 120 TABLET in 1 BOTTLE (62135-607-12)
source: ndc

Packages (1)

62135-607-12 120 TABLET in 1 BOTTLE (62135-607-12)

Ingredients (1)

acetazolamide (125 mg/1)

Linked Drug Pages (1)

Acetazolamide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "2420d256-1179-5cf2-e063-6394a90ae9a2", "openfda": {"nui": ["N0000175517", "N0000000235", "M0020790"], "upc": ["0362135607128", "0362135608125"], "unii": ["O3FX965V0I"], "rxcui": ["197303", "197304"], "spl_set_id": ["f75bbf55-98ac-4f91-b6fd-17b5ac860e55"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_epc": ["Carbonic Anhydrase Inhibitor [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]"], "manufacturer_name": ["Chartwell RX, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "120 TABLET in 1 BOTTLE (62135-607-12)", "package_ndc": "62135-607-12", "marketing_start_date": "20230509"}], "brand_name": "Acetazolamide", "product_id": "62135-607_2420d256-1179-5cf2-e063-6394a90ae9a2", "dosage_form": "TABLET", "pharm_class": ["Carbonic Anhydrase Inhibitor [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "62135-607", "generic_name": "Acetazolamide", "labeler_name": "Chartwell RX, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acetazolamide", "active_ingredients": [{"name": "ACETAZOLAMIDE", "strength": "125 mg/1"}], "application_number": "ANDA205530", "marketing_category": "ANDA", "marketing_start_date": "20161027", "listing_expiration_date": "20261231"}